Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Lifestyle Intervention to Reduce Body Weight and Systemic Inflammation Among World Trade Center Responders

17. listopadu 2021 aktualizováno: Chrisa Arcan, PhD, MHS, MBA, RD, Stony Brook University

Lifestyle Intervention to Reduce Body Weight and Systemic Inflammation Among World Trade Center Responders With PTSD: Pilot Randomized Controlled Trial

The goal of this randomized control trial (RCT) is to test the feasibility and acceptability of a lifestyle intervention with a focus on implementing a high dose Mediterranean Diet protocol with physical activity to reduce systemic inflammation and body weight among WTC first responders having overweight/obesity and PTSD. The findings of this study will demonstrate the suitability of the proposed approach to reduce comorbidities among similar populations exposed to traumatic events; the findings will also inform the World Trade Center Health Program's extensive research and clinical efforts with the potential to provide a preventive care model to reduce systemic inflammation and related chronic disease among WTC responders with PTSD.

Přehled studie

Detailní popis

The proposed study will assess the feasibility and acceptability of a lifestyle intervention, including a Mediterranean Diet (MedDiet) with a physical activity (PA) component. The study is a pilot randomized control trial (RCT) among WTC responders with PTSD who have overweight and obesity. The 10-week intervention has two-arms, the intervention (MedDiet) with tips to increase PA (n=30) and control (care as usual n=30).

The high dose and high fidelity intervention combines several previously tested intervention modalities, including individual nutrition counseling, group cooking sessions, and communication and education through smartphones, including motivational texts & reminders, videos, teach-back surveys, and goal setting. While the main goal of the intervention is to assess the feasibility and acceptability of the intervention, the study will also assess changes in the overall dietary intake, the MedDiet score, and PA of the intervention group and between the two groups from baseline, post-intervention, and 3-month follow-up. The hypothesis is that the intervention group will experience a significant increase in the MedDiet score and PA activity from baseline to post-intervention; compared to the control group, the intervention group will achieve a significantly higher MedDiet score and will engage in more PA after the intervention.

Changes in body weight, inflammatory biomarkers, and prevalence of metabolic syndrome (MetS) in the intervention group and between the two groups from baseline to post-intervention will be explored; whether changes in inflammatory biomarkers, are moderated by changes in MetS, body weight, or MedDiet score will also be explored. The hypothesis is that the intervention group will experience a significant decrease in inflammatory biomarkers and prevalence in MetS from baseline to post-intervention; compared to the control group, the intervention group will achieve a significantly higher decrease in these measures; the decline in inflammatory biomarkers will be moderated by a reduction in the prevalence of MetS and/or increase in MedDiet score.

Typ studie

Intervenční

Zápis (Aktuální)

62

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • New York
      • Commack, New York, Spojené státy, 11725
        • World Trade Center Health Program Clinic

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

40 let až 65 let (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • BMI range: 27-40
  • PCL score: ≥40
  • MOCA score: ≥22
  • have a smartphone
  • able to follow a diet intervention
  • no physical disabilities which prevent exercising

Exclusion Criteria:

  • active cancer or history of GI-related cancer in the last 3 years
  • autoimmune disease
  • history of surgical weight loss

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Jiný
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Singl

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Mediterranean Diet & Physical Activity
Nutrition with a Physical Activity component. 10-week intervention implementing the Mediterranean Diet.

At the beginning of each week (1-10), members were sent a text message introducing the week and providing the link to the week's website. This website includes downloadable material for this group with recipes and other important nutrition information, as well as the weekly topic information and informative video. After receiving the link to the website, members received a Qualtrics survey with a teach-back question related to the video and a goal-setting question related to the topics of the week. At the end of each week, members received another Qualtrics survey with a question regarding the goal of the past week.

  • Visit 1: discuss Mediterranean diet score results from baseline and ways to improve
  • Visit 2: discuss anti-inflammatory diet scorecard and ways to improve
  • Discuss optimal dietary pattern (Med Diet pyramid handout)
  • Personal dietary and exercise goals, reviewed baseline intake form, social support, self-efficacy, challenges, or barriers to achieving goals
Ostatní jména:
  • Nutriční intervence
Aktivní komparátor: Usual Care
Usual care involves one-on-one monthly nutrition counseling
As part of usual care, members attended one-on-one monthly counseling sessions with the assigned dietitian and reviewed their current eating habits and physical activity, as well as other environmental factors that may be affecting their weight such as work, home environment, sleeping issues, and medications. After reviewing current practices, the RD provided medical nutrition therapy (MNT), a specific application of the Nutrition Care Process in clinical settings that focuses on the management of diseases (e.g. diabetes, heart disease, etc.). Specific dietary recommendations are based on the Bull's Eye Food Guide, used by Stony Brook University Hospital for outpatient nutrition counseling. Individuals in the standard care received more individualized calorie recommendations (usual care) than the Mediterranean diet group.
Ostatní jména:
  • Řízení

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Mediterranean diet score
Časové okno: 9 months

Participant's Mediterranean diet score is measured with a 14-item Mediterranean diet scale; possible score range 0-14.

The Mediterranean Diet questionnaire will be given at each participant visit with the dietitians and at baseline, post, and at 3-month follow up

9 months

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Physical activity
Časové okno: 9 months
Daily step count is measured with Fitbit that was worn over seven days. Physical activity are measured at baseline, post-intervention, and 3-month follow up.
9 months
Body mass index (BMI)
Časové okno: 9 months

Body mass index (weight/height square) will be objectively measured at baseline, post intervention and at 3-month follow up.

Body mass index: weight in kilograms/square of height in meters

9 months
Waist Circumference
Časové okno: 9 months

Waist circumference is measured at baseline, post-intervention, and 3-month follow up.

Waist circumference cut off (Women>88cm; Men>102 cm)

9 months
Total cholesterol
Časové okno: 9 months
Total cholesterol is measured at baseline, post-intervention, and at 3-months follow-up; reference range: 125 to 200mg/dL
9 months
oxidized LDL
Časové okno: 9 months
Serum oxLDL is measured at baseline, post-intervention, and at 3-months follow-up; reference range: 10-170 ng/mL
9 months
HDL cholesterol
Časové okno: 9 months

Serum HDL cholesterol was measured at baseline, post-intervention, and at 3-months follow-up;

At risk Men: Less than 40 mg/dL (1.0 mmol/L) Women: Less than 50 mg/dL (1.0 mmol/L)

9 months
Omega 3 fatty acid
Časové okno: 9 months

Serum or plasma Free (Nonester) Fatty Acids Measured at baseline, post-intervention, and at 3-months follow-up. reference range:

Optimal >3.2 % Moderate 2.2-3.2 % High <2.2 %

9 months
Omega 6 to omega 3 ratio
Časové okno: 9 months

Omega 6 is measured at baseline, post-intervention, and at 3-months follow-up;

Omega 6/omega 3 ratio:

Reference range: 5.7-21.3 (the lower the better)

9 months
HA1c
Časové okno: 9 months

Serum Hemoglobin A1C (hA1C) is measured at baseline, post-intervention, and 3-month follow up.

hA1C: Normal: <5.7%

9 months
Cytokines
Časové okno: 6 months

The following cytokines will be measured:

FNɣ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-22 and TNFα, high-sensitivity C-reactive protein (hs-CRP) at >3mg/L.

The cytokines will be measured at two time points at baseline and post-intervention.

6 months
Psychosocial questionnaire
Časové okno: 9 months
A total of 40 questions will be used to assess sedentary behaviors, home food availability, social support, self-efficacy, perceived barriers to adhering to lifestyle behaviors reflecting the behavioral strategies that will be addressed in the proposed intervention. The survey will be completed online at baseline, post-intervention and at 3-month follow up.
9 months
PCL score
Časové okno: 9 months
Post Traumatic Stress Disorder symptoms will be tested with a PCL score. PCL is a 20-item self-report measure of current (past month) PTSD symptoms based on the DSM-V criteria. PCL will be measured at baseline, post intervention and at 3-month follow up
9 months

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

1. prosince 2020

Primární dokončení (Očekávaný)

30. listopadu 2021

Dokončení studie (Očekávaný)

30. listopadu 2021

Termíny zápisu do studia

První předloženo

7. srpna 2021

První předloženo, které splnilo kritéria kontroly kvality

17. listopadu 2021

První zveřejněno (Aktuální)

30. listopadu 2021

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

30. listopadu 2021

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

17. listopadu 2021

Naposledy ověřeno

1. listopadu 2021

Více informací

Termíny související s touto studií

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit